SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-147494
Filing Date
2022-05-11
Accepted
2022-05-11 16:06:19
Documents
55
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 6-K d270314d6k.htm   iXBRL 6-K 116834
2 EX-99.1 d270314dex991.htm   iXBRL EX-99.1 876489
3 EX-99.2 d270314dex992.htm EX-99.2 190586
9 GRAPHIC g270314g0503030507515.jpg GRAPHIC 8817
10 GRAPHIC g270314g0503030507952.jpg GRAPHIC 17716
11 GRAPHIC g270314g61h52.jpg GRAPHIC 143619
  Complete submission text file 0001193125-22-147494.txt   5303021

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA asnd-20220331.xsd EX-101.SCH 46622
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asnd-20220331_cal.xml EX-101.CAL 39037
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asnd-20220331_def.xml EX-101.DEF 195413
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE asnd-20220331_lab.xml EX-101.LAB 318962
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asnd-20220331_pre.xml EX-101.PRE 258890
49 EXTRACTED XBRL INSTANCE DOCUMENT d270314d6k_htm.xml XML 953968
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 22913700
SIC: 2834 Pharmaceutical Preparations